Free National NPI Number Registry

Amr M Aref

Home > Amr M Aref

 

NPI Number Detailed Information

Provider Information:

Name: Amr M Aref
Gender: M
Provider License Number If Given: 58493

NPI Information:

NPI: 1003832585
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 7/15/2006

Last Update Date: 12/26/2013

Reputation Report:

Provider Business Mailing Address:

Address: 19229 MACK AVE SUITE 10
Grosse Pointe Woods, MI 48236
Phone Number: 3136473100
Fax Number: 3136473111

Provider Business Practice Location Address:

Address: 19229 MACK AVE SUITE 10
Grosse Pointe Woods, MI 48236
Phone Number: 3136473100
Fax Number: 3136473111

Provider Taxonomy:

Primary: 2085R0001X
Secondary (if any): 2085R0001X
State: MI

Top Doctors in MI

 

About Amr M Aref

Amr M Aref ( AMR M AREF ) is A Radiology Physician in Grosse Pointe Woods, MI. The NPI Number for Amr M Aref is 1003832585.
The current location address for Amr M Aref is 19229 MACK AVE SUITE 10 Grosse Pointe Woods, MI 48236 and the contact number is 3136473100 and fax number is 3136473111. The mailing address for Amr M Aref is 19229 MACK AVE SUITE 10 Grosse Pointe Woods, MI 48236- 3136473100 (mailing address contact number - 3136473100).
A radiologist who deals with the therapeutic applications of radiant energy and its modifiers and the study and management of disease, especially malignant tumors.

Provider Business Location on Map

FAQs:

What is the NPI Number for Amr M Aref ?


Answer: The NPI Number for Amr M Aref is 1003832585

Where is Amr M Aref located?


Answer: Amr M Aref is located at 19229 MACK AVE SUITE 10 Grosse Pointe Woods, MI 48236.

What is the specialty for Amr M Aref ?


Answer: The Specialty of Amr M Aref is A Radiology Physician.

Are there any online reviews for Amr M Aref ?


Answer: Yes! Check It Now.

Are there any other health care providers in Grosse Pointe Woods, MI?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Amr M Aref

Number of HCPCS 41
Number of Medicare Beneficiaries 161
Number of Services 3108
Total Submitted Charge Amount 1612901
Total Medicare Allowed Amount 423579.48
Total Medicare Payment Amount 337877.08
Total Medicare Standardized Payment Amount 352715.21
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 1
Number of Medicare Beneficiaries With Drug Services 11
Number of Drug Services 792
Total Drug Submitted Charge Amount 990
Total Drug Medicare Allowed Amount 92.03
Total Drug Medicare Payment Amount 73.65
Total Drug Medicare Standardized Payment Amount 72.2
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 40
Number of Medicare Beneficiaries With Medical 161
Number of Medical Services 2316
Total Medical Submitted Charge Amount 1611911
Total Medical Medicare Allowed Amount 423487.45
Total Medical Medicare Payment Amount 337803.43
Total Medical Medicare Standardized Payment Amount 352643.01
Average Age of Beneficiaries 74
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74 86
Number of Beneficiaries Age 75 to 84 48
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries 75
Number of Male Beneficiaries 86
Number of Non-Hispanic White Beneficiaries 138
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement 18
Number of Beneficiaries With Medicare Only Entitlement 143
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.15
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.11
Percent (%) of Beneficiaries Identified With Asthma 0.08
Percent (%) of Beneficiaries Identified With Cancer 0.69
Percent (%) of Beneficiaries Identified With Heart Failure 0.22
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.4
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.3
Percent (%) of Beneficiaries Identified With Depression 0.22
Percent (%) of Beneficiaries Identified With Diabetes 0.35
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.66
Percent (%) of Beneficiaries Identified With Hypertension 0.72
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.4
Percent (%) of Beneficiaries Identified With Osteoporosis 0.11
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.42
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries 1.6569

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Radiation Oncology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 171
Number of Standardized 30-Day Fills 224
Aggregate Cost Paid for All Claims 4154.17
Number of Day's Supply for All Claims 5282
Number of Medicare Beneficiaries 75
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst *
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 161
Aggregate Cost Paid for Generic Drugs 3580.54
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst #
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 63
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 1895.27
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 108
Aggregate Cost Paid for Claims Filled by 2258.9
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 26
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 866.48
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 145
by Low-Income Subsidy 3287.69
Total Claims of Opioid Drugs, Including 21
Aggregate Cost Paid for Opioid Drugs 1448.41
Opioid Claims 15
Opioid_Tot_Clms divided by the Tot_Clms 12.280701754
Total Claims of Long-Acting Opioid Drugs 15
Aggregate Cost Paid for Long-Acting Opioid 1322.34
Number of Day's Supply of All Long-Acting 405
Long-Acting Opioid Claims 13
Opioid_LA_Tot_Clms divided by the 71.428571429
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst *
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries 73.04
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries 20
Number of Male Beneficiaries 55
Number of Non-Hispanic White 58
Number of Black or African American 11
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category 1.2440011111

More Providers in grosse-pointe-woods , mi

amr M aref in Other Directories

Provider don't have other directory link yet.